VANGUARD GROUP INC - 31 Dec 2024 SCHEDULE 13G/A Report for TG Therapeutics Inc Common Stock (TGTX)

Filing Manager
VANGUARD GROUP INC
Reporting Manager
The Vanguard Group
Symbol
TGTX
Shares outstanding
156M shares
Disclosed Ownership
15.6M shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
08 Jan 2025, 11:29:53 UTC
Date of event
31 Dec 2024

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
The Vanguard Group 10.01% 15.6M 0 267K Ashley Grim Head of Global Fund Administration